Disease: hepatitis B

Leveraging polysaccharide-derived nanocarriers to open new horizons in oral vaccine activation

mycolabadmin

Oral vaccines are easier to administer than injections, but the stomach’s harsh environment destroys them before they work. Scientists are developing special nanocarrier particles made from natural plant materials, especially those used in traditional Chinese medicine, that protect vaccine ingredients and trigger stronger immune responses in the gut. These carriers work like protective vehicles that deliver vaccines safely to immune cells in the intestines, potentially revolutionizing how we vaccinate people worldwide.

Read More »

Bibliometric analysis of traditional Chinese medicine for viral infections through immune modulation (2015–2025)

mycolabadmin

This research analyzed over 3,300 scientific papers published between 2015-2025 to understand how traditional Chinese medicine helps fight viral infections by boosting the immune system. The study found that research on this topic has grown significantly, especially during disease outbreaks like COVID-19, with China leading in research publications. Key findings show that traditional Chinese herbal compounds work through multiple mechanisms including directly fighting viruses, reducing excessive inflammation, and enhancing vaccine effectiveness. The research points toward promising future applications of traditional Chinese medicine when combined with modern medical approaches.

Read More »

Unveiling the full spectrum of maitake mushrooms: A comprehensive review of their medicinal, therapeutic, nutraceutical, and cosmetic potential

mycolabadmin

Maitake mushrooms, long used in Asian traditional medicine, contain powerful compounds that may help fight cancer, support immune function, manage blood sugar, and protect skin health. Research shows they can inhibit bacterial and viral infections, reduce tumor growth in various cancer types, and improve overall metabolic health. These mushrooms can be incorporated into food-based supplements and skincare products. While promising results have been seen in laboratory and animal studies, more human clinical trials are needed to fully understand their benefits and safety.

Read More »

Influenza-related invasive pulmonary aspergillosis in an infectious disease ward at a pulmonary referral center in Iran

mycolabadmin

This study examined patients hospitalized with influenza who developed a serious fungal infection caused by Aspergillus fungus. Among 109 influenza patients, about 9% developed this fungal complication which significantly increased their risk of death and required longer hospital stays. Patients with existing lung diseases were at higher risk, and those with the fungal infection also had more bacterial superinfections. The findings highlight the importance of recognizing and treating this serious fungal complication in hospitalized influenza patients.

Read More »
Scroll to Top